Statistics
Publications
20
Citations
972
H-Index
16
Active since
2004
Roy Haskell is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, pharmacy, and drug discovery.
Publications per year
2004–2024
20
20
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
Jennifer Cantley, Xiaofen Ye, Emma Rousseau et al. · Nature Communications · 2022 · 129 citations · Full text
Huijun Chen, Yipshu Pui, Chengyu Liu et al. · Journal of Pharmaceutical Sciences · 2017 · 71 citations
Natural Sciences, Materials Engineering, Materials Science +17
1–5 of 20